Radiation Oncology-Methodist is categorized under Oncologists in Philadelphia, PA and active since 2011.
Radiation Oncology-Methodist was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Alisa Itri, Administrator at the company’s single location by writing to 1302 Wolf St, Philadelphia, Pennsylvania PA 19148 or by phoning (215) 952-1444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Radiation Oncology-Methodist |
| Contact Person: | Alisa Itri, Administrator |
| Address: | 1302 Wolf St, Philadelphia, Pennsylvania 19148 |
| Phone Number: | (215) 952-1444 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Radiation Oncology-Methodist was started in 2011 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Alisa Itri, Administrator for inquiries that concern Radiation Oncology-Methodist by calling the company number (215) 952-1444, as your correspondence is most welcome. Additionally, the physical location of the single location of Radiation Oncology-Methodist can be found at the coordinates 39.92161,-75.16821 as well as the street address 1302 Wolf St in Philadelphia, Pennsylvania 19148.
For its online presence, you may visit Radiation Oncology-Methodist’s website at and engage with its social media outlets through on Twitter and on Facebook.